Clinical Trials Directory

Trials / Completed

CompletedNCT04344002

LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)

Observational Retrospective Register of Spanish Lung and Melanoma Cancer Patients With COVID19 Disease

Status
Completed
Phase
Study type
Observational
Enrollment
886 (actual)
Sponsor
Spanish Lung Cancer Group · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is a multi-centre study on lung cancer patients which experienced COVID-19. Information on clinical features, clinical course, management and outcomes will be collected for both, thoracic cancers and COVID-19 infection. Firstly, investigators will be registered in an online secure registry. After that, a protocol will be developed in order to collect clinical data for the research. It will also include I on the care organization or the perception of the patient and their family members. The final stage will consist on retrospective data collection from patients. So, it is a retrospective study data collection, preceded by prospective data registry.

Conditions

Timeline

Start date
2020-04-21
Primary completion
2021-10-06
Completion
2021-10-06
First posted
2020-04-14
Last updated
2022-06-27

Locations

75 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT04344002. Inclusion in this directory is not an endorsement.

LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID) (NCT04344002) · Clinical Trials Directory